Extended Data Fig. 3: Re-treatment of patients with acute lymphoblastic leukemia (ALL) with cryopreserved CD19-CAR T-cells. | Nature Medicine

Extended Data Fig. 3: Re-treatment of patients with acute lymphoblastic leukemia (ALL) with cryopreserved CD19-CAR T-cells.

From: BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells

Extended Data Fig. 3

a, Expansion dynamics of the second CD19-CAR T-cell therapy in three patients with acute lymphoblastic leukemia (ALL). b, Viability of CD3+ T-cells in the CD19-CAR T-cell product (live and after cryopreservation). c, Quantification of the anti-CAR T-cell response in N = 12 control donors and ALL patient 02.

Back to article page